[
  {
    "ts": null,
    "headline": "REGN IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action - REGN",
    "summary": "WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30, 2024, both dates inclusive , of...",
    "url": "https://finnhub.io/api/news?id=09d1ec7adbc943bc6725b1dd10ba569134d7f9b121b508404463acb58be26d6a",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740920463,
      "headline": "REGN IMPORTANT DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Regeneron Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action - REGN",
      "id": 132944054,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30, 2024, both dates inclusive , of...",
      "url": "https://finnhub.io/api/news?id=09d1ec7adbc943bc6725b1dd10ba569134d7f9b121b508404463acb58be26d6a"
    }
  },
  {
    "ts": null,
    "headline": "REGN Deadline: REGN Investors with Losses in Excess of $100K Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
    "summary": "NEW YORK, March 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30,...",
    "url": "https://finnhub.io/api/news?id=5eba3687cb3aa73733fe0095fb7ac85dc224dd8481ed4c33c39176ceef1f39d3",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740919984,
      "headline": "REGN Deadline: REGN Investors with Losses in Excess of $100K Have Opportunity to Lead Regeneron Pharmaceuticals, Inc. Securities Fraud Lawsuit",
      "id": 132944011,
      "image": "",
      "related": "REGN",
      "source": "Finnhub",
      "summary": "NEW YORK, March 2, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regeneron Pharmaceuticals, Inc. between November 2, 2023 and October 30,...",
      "url": "https://finnhub.io/api/news?id=5eba3687cb3aa73733fe0095fb7ac85dc224dd8481ed4c33c39176ceef1f39d3"
    }
  },
  {
    "ts": null,
    "headline": "Invest In A New Biotech Bull Market With XBI And IBB",
    "summary": "Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an attractive sector now.",
    "url": "https://finnhub.io/api/news?id=3edf6e48bd25aa568b9ee4bde4307faaa0b7ac715a16ade17f41d2be3765f8a9",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1740904387,
      "headline": "Invest In A New Biotech Bull Market With XBI And IBB",
      "id": 132943007,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1215526952/image_1215526952.jpg?io=getty-c-w1536",
      "related": "REGN",
      "source": "SeekingAlpha",
      "summary": "Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an attractive sector now.",
      "url": "https://finnhub.io/api/news?id=3edf6e48bd25aa568b9ee4bde4307faaa0b7ac715a16ade17f41d2be3765f8a9"
    }
  }
]